Doctors Don’Â’t Agree on Bextra Risk
The evidence behind the risk of Bextra isn’t nearly as conclusive as Vioxx, so far. This story details the preliminary nature of the data.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Health care as a human right vs. commodity: Resolving the paradox
-
My wife’s story: How DEA and CDC guidelines destroyed our golden years
-
Why voicemail in outpatient care is failing patients and staff
-
Stopping medication requires as much skill as starting it [PODCAST]
-
Weaponizing food allergies in entertainment endangers lives [PODCAST]
-
Post-stroke cognitive impairment: the hidden challenge of recovery
-
Past 6 Months
-
How environmental justice and health disparities connect to climate change
-
Will AI replace primary care physicians?
-
A physician father on the Dobbs decision and reproductive rights
-
What is the minority tax in medicine?
-
Why the U.S. health care system is failing patients and physicians
-
Alex Pretti: a physician’s open letter defending his legacy
-
Recent Posts
-
Weaponizing food allergies in entertainment endangers lives [PODCAST]
-
Geriatric diabetes management: Why strict A1c targets can harm seniors
-
Why progression independent of relapse activity is the silent driver of disability in multiple sclerosis
-
Why medical school DEI mission statements matter for future physicians
-
A physician’s quiet reflection on January 1, 2026
-
AI censorship threatens the lifeline of caregiver support [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
